GeneReach Biotechnology Free Cash Flow Generation Index
GeneReach Biotechnology free cash flow generation index. GeneReach Biotechnology (4171) has a Free Cash Flow Generation Index of -0.29x as of June 2026. Free cash flow of NT$-1.85 Million represents 0% of operating cash flow (NT$6.28 Million).
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Free Cash Flow Generation Index of GeneReach Biotechnology (2018–2022)
Free cash flow generation index of GeneReach Biotechnology from 2018 to 2022. Historical FCF Generation Index trend for GeneReach Biotechnology across 4 annual periods. See GeneReach Biotechnology (4171) flexibility index to measure the company's free cash flow as a share of total liabilities.
GeneReach Biotechnology Free Cash Flow Generation Index by Year (2018–2022)
GeneReach Biotechnology free cash flow generation index by year from 2018 to 2022. Year-by-year Free Cash Flow Generation Index for GeneReach Biotechnology. For the full cash flow conversion analysis, see GeneReach Biotechnology (4171) cash flow conversion.
| Year | FCG Index | Free Cash Flow (TWD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2022 | 0.87x | NT$312.73 Million | NT$357.63 Million | NT$44.90 Million | ▼ -8.4% |
| 2021 | 0.95x | NT$333.20 Million | NT$348.99 Million | NT$15.79 Million | ▲ +54.5% |
| 2020 | 0.62x | NT$104.95 Million | NT$169.82 Million | NT$64.87 Million | ▲ +3.3% |
| 2018 | 0.60x | NT$3.44 Million | NT$5.74 Million | NT$2.31 Million | — |